Screener
Revolution Medicines, Inc. RVMD Total debt
Total debt at other companies
Other financials
Where this comes from
Computed from long term debt + current portion long term debt + short term borrowings + operating lease liabilities + finance lease liabilities + financing obligations: $156.63M.
The source filing: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:10 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-208969
FAQ
- What is Revolution Medicines, Inc.'s total debt?
- Revolution Medicines, Inc. (RVMD) reported total debt of $156.63M in Q1 2026.
- How has Revolution Medicines, Inc.'s total debt changed year-over-year?
- Revolution Medicines, Inc.'s total debt increased by 16.6% year-over-year, from $134.34M to $156.63M.
- What is the long-term trend for Revolution Medicines, Inc.'s total debt?
- Over 5 years (2020 to 2025), Revolution Medicines, Inc.'s total debt has grown at a 37.2% compound annual growth rate (CAGR), from $32.68M to $158.7M.
- What does total debt mean?
- Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.
Ask your AI about Revolution Medicines, Inc.'s total debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude